Early microdose drug studies in human volunteers can minimise animal testing: Proceedings of a workshop organised by Volunteers in Research and Testing
- 28 April 2003
- journal article
- editorial
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 19 (1) , 1-11
- https://doi.org/10.1016/s0928-0987(03)00040-x
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Cryogenic Probe 13C NMR Spectroscopy of Urine for Metabonomic StudiesAnalytical Chemistry, 2002
- PET Studies with Carbon-11 Radioligands in Neuropsychopharmacological Drug DevelopmentCurrent Pharmaceutical Design, 2001
- A validation study comparing accelerator MS and liquid scintillation counting for analysis of 14C-labelled drugs in plasma, urine and faecal extractsJournal of Pharmaceutical and Biomedical Analysis, 2000
- Concordance of the Toxicity of Pharmaceuticals in Humans and in AnimalsRegulatory Toxicology and Pharmacology, 2000
- Optimizing the science of drug development: opportunities for better candidate selection and accelerated evaluation in humansEuropean Journal of Pharmaceutical Sciences, 2000
- Biomedical applications of accelerator mass spectrometry-isotope measurements at the level of the atomRapid Communications in Mass Spectrometry, 1999
- The advantage of using positron emission tomography in drug researchTrends in Neurosciences, 1996
- New drug development in the United States from 1963 to 1992Clinical Pharmacology & Therapeutics, 1994
- Radiological protection in biomedical researchAnnals of the ICRP, 1991
- Model Selection in Toxicology: Principles and PracticeJournal of the American College of Toxicology, 1990